(Q42093452)

English

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

scientific article published on March 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy (English)

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

prostate cancer

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Philip W. Kantoff

9

object named as

Philip W Kantoff

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Mary-Ellen Taplin

8

object named as

Mary-Ellen Taplin

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Toni K Choueiri

1

object named as

Toni K Choueiri

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Meredith M Regan

7

object named as

Meredith M Regan

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Anthony V D'Amico

3

object named as

Anthony V D'Amico

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

author name string

Wanling Xie

2

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Robert W Ross

4

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Jim C Hu

5

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Mark Pomerantz

6

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Oliver Sartor

10

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

language of work or name

0 references

publication date

1 March 2009

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

115

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

5

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

981-987

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931827

29 May 2018

Drug insight: role of the androgen receptor in the development and progression of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931827

29 May 2018

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931827

29 May 2018

Development of an integrated prostate cancer research information system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931827

29 May 2018

Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931827

29 May 2018

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931827

29 May 2018

PSA evolution: a prognostic factor during treatment of advanced prostatic carcinoma with total androgen blockade. Data from a Belgian multicentric study of 546 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931827

29 May 2018

Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? Joint research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931827

17 August 2018

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2931827

17 August 2018

Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19152438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19152438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19152438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.24064

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42093452&oldid=2238046962"